🇺🇸 FDA

Company profile · Sponsor

Voyager

Voyager Therapeutics

VYGR · NYSE biotech LEXINGTON, MA, USA
Pipeline
4
Drugs
0
Patents
8

Quick answer

Voyager (VYGR) is a biotech company. headquartered in LEXINGTON, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker VYGR
Exchange NYSE
Company type biotech
Headquarters LEXINGTON, MA, USA
SEC CIK 0001640266

Pipeline (4)

Search pipeline →

  1. VP4896

    Voyager

    Alzheimer's Disease

    phase 3 small molecule completed

    1 trial

  2. Leuprolide acetate

    Voyager

    Alzheimer Disease

    phase 2 small molecule completed

    2 trials

  3. VY7523

    Voyager

    Alzheimer's Disease (AD)

    phase 2 small molecule active

    1 trial

  4. Intraparenchymal rAAV1 - (mi)RNA HTT

    Voyager

    Huntington Disease

    phase 1 gene therapy terminated

    1 trial

Patents (8)

Search patents →

  1. US 12419969

    AAV capsid variants and uses thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12319929

    Compositions and methods for the treatment of Parkinson's disease

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12305189

    Compositions and methods for delivery of AAV

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12296025

    AAV capsid variants and uses thereof

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12291565

    Tau binding compounds

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12281321

    Frataxin expression constructs having engineered promoters and methods of use thereof

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12252703

    Closed-ended linear duplex DNA for non-viral gene transfer

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12146150

    Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Voyager?

Voyager (VYGR) is a biotech company. headquartered in LEXINGTON, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Voyager sponsor?

We track 4 ClinicalTrials.gov-linked programs for Voyager, including VP4896 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Voyager company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.